Maximizing Efficiency In Data Management Services In A Breast Cancer Study
Source: OCT Clinical
Mabscale LLC is an innovative biopharmaceutical company engaged in the development and production of medicines based on monoclonal antibodies and other recombinant proteins. The company is a biotechnological project of Ozon Pharmaseuticals, which offers generic products, antivirals, antibiotics, oxidase inhibitors, calcium, and other drugs.
Learn how database validation, database lock, and the development of the electronic CRF were used in partnership with Mabscale in a HER2-positive operable breast cancer study.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
OCT Clinical
This website uses cookies to ensure you get the best experience on our website. Learn more